Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2012

01-01-2012 | 2011 SSAT Plenary Presentation

Gastrointestinal Metabolic Surgery for the Treatment of Diabetic Patients: A Multi-Institutional International Study

Authors: Wei-Jei Lee, Kyung Yul Hur, Muffazal Lakadawala, Kazunori Kasama, Simon K. H. Wong, Yi-Chih Lee

Published in: Journal of Gastrointestinal Surgery | Issue 1/2012

Login to get access

Abstract

Background

Gastrointestinal metabolic surgery has been proposed for the treatment of not well-controlled type 2 diabetes mellitus (T2DM) patients with a body mass index (BMI) <35 kg/m2. This study aims to describe recent experience with surgical treatment of T2DM in Asian centers.

Methods

Patients aged 20 to 70 years with not well-controlled T2DM [glycated hemoglobin (HbA1C) >7.0%] and BMI < 35 kg/m2 were included at five institutes between 2007 and 2010. The end point is T2DM remission, defined by fasting plasma glucose <110 mg/dl and HbA1C <6.0%.

Results

Of the 200 patients, 172 (86%) underwent gastric bypass, 24 (12%) underwent sleeve gastrectomy, and the other 4 underwent adjustable banding. Laparoscopic access was used in all the patients. Gender (66.5% female), age (mean 45.0 ± 10.8), and HbA1C (mean 9.3 ± 1.9%) did not differ between the procedure among the groups. Until now, 87 patients had 1-year data. One year after surgery, the mean BMI decreased from 28.5 ± 3.0 to 23.4 ± 2.3 kg/m2 and HbA1C decreased to 6.3 ± 0.5%. Remission of T2DM was achieved in 72.4% of the patients. Patients with a diabetes duration of <5 years had a better diabetes remission rate than patients with duration of diabetes >5 years (90.3% vs. 57.1%; p = 0.006). Patients with BMI > 30 kg/m2 had a better diabetes remission rate than those with BMI < 30 kg/m2 (78.7% vs. 62.5%; p = 0.027). Individuals who underwent gastric bypass loss more weight and had a higher diabetes remission rate than individuals who underwent restrictive-type procedures. Multivariate analysis confirmed that the duration of diabetes and the type of surgery predict the diabetes remission. No mortalities were reported and two (1.0%) patients had major morbidities.

Conclusion

Gastrointestinal metabolic surgery is an effective treatment for not well-controlled T2DM treatment. Diabetes remission is significantly higher in those with duration of diabetes less than 5 years and BMI > 30 kg/m2.
Literature
1.
go back to reference King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431.PubMedCrossRef King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431.PubMedCrossRef
2.
go back to reference Zimmer P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787.CrossRef Zimmer P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787.CrossRef
3.
go back to reference Diabetes Control and Complications Trial. The relationship of glycemic exposure (HbA sub1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968–983.CrossRef Diabetes Control and Complications Trial. The relationship of glycemic exposure (HbA sub1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968–983.CrossRef
4.
go back to reference UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.CrossRef UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.CrossRef
5.
go back to reference UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet 1998;352:854–865.CrossRef UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet 1998;352:854–865.CrossRef
6.
go back to reference Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995;222:339–352.PubMedCrossRef Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995;222:339–352.PubMedCrossRef
7.
go back to reference Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358–363.PubMedCrossRef Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358–363.PubMedCrossRef
8.
go back to reference Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467–485.PubMed Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467–485.PubMed
9.
go back to reference Sjostrom L, Lindroos AK, Peltonen M, Scia DA, Clore JN. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM 2004;351:2683–2693.PubMedCrossRef Sjostrom L, Lindroos AK, Peltonen M, Scia DA, Clore JN. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM 2004;351:2683–2693.PubMedCrossRef
10.
go back to reference Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462–473.PubMedCrossRef Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462–473.PubMedCrossRef
11.
go back to reference Vidal J, Ibarzabai F, Romero F, Deigado S, Momblan D, Lacy FA. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008;18:1077–1082.PubMedCrossRef Vidal J, Ibarzabai F, Romero F, Deigado S, Momblan D, Lacy FA. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008;18:1077–1082.PubMedCrossRef
12.
go back to reference Lee Wj, Lee YC, Ser KH, Chen JC, Chen SC. Effect of diabetes resolution after bariatric surgery in Asian patients. World J Surg 2009;18:1119–1125. Lee Wj, Lee YC, Ser KH, Chen JC, Chen SC. Effect of diabetes resolution after bariatric surgery in Asian patients. World J Surg 2009;18:1119–1125.
13.
go back to reference Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010;251:399–405.PubMedCrossRef Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit Consensus Conference: Recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010;251:399–405.PubMedCrossRef
14.
go back to reference Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 Kg/m2: a tailored approach. Surg Obes Related Diseas 2006;2:401–404.CrossRef Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 Kg/m2: a tailored approach. Surg Obes Related Diseas 2006;2:401–404.CrossRef
15.
go back to reference Depaula AL, Macedo ALV, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endos 2007;22:706–716CrossRef Depaula AL, Macedo ALV, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endos 2007;22:706–716CrossRef
16.
go back to reference Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 Kg/m2. J Gastrointest Surg 2008;12:945–952PubMedCrossRef Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 Kg/m2. J Gastrointest Surg 2008;12:945–952PubMedCrossRef
17.
go back to reference Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index < 35 Kg/m2. Surg Obes & Related Dis 2010;6:332–339.CrossRef Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index < 35 Kg/m2. Surg Obes & Related Dis 2010;6:332–339.CrossRef
18.
go back to reference Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg 2010;252:559–567.PubMed Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg 2010;252:559–567.PubMed
19.
go back to reference Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg 2005;15:648–654.PubMedCrossRef Wang W, Wei PL, Lee YC et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg 2005;15:648–654.PubMedCrossRef
20.
go back to reference Lee WJ, Yu PY, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005;242:20–28.PubMedCrossRef Lee WJ, Yu PY, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005;242:20–28.PubMedCrossRef
21.
go back to reference Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg 2006;16:586–91.PubMedCrossRef Lee WJ, Wang W, Yu PJ et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg 2006;16:586–91.PubMedCrossRef
22.
go back to reference Ser KH, Lee WJ, Lee YC, et al. Laparoscopic sleeve gastrectomy. Surg Endos 2010;24:2253–2259.CrossRef Ser KH, Lee WJ, Lee YC, et al. Laparoscopic sleeve gastrectomy. Surg Endos 2010;24:2253–2259.CrossRef
23.
go back to reference Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133–2135.PubMedCrossRef Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133–2135.PubMedCrossRef
24.
go back to reference Cybenko G. Approximation by superpositions of a sigmoidal Function. Math Control Signal 1989; 2: 303–314.CrossRef Cybenko G. Approximation by superpositions of a sigmoidal Function. Math Control Signal 1989; 2: 303–314.CrossRef
25.
go back to reference Hornik K, Stinchcombe M, White H. Multilayer feed forward networks are universal approximations. Neural Networks 1989; 2: 336–359.CrossRef Hornik K, Stinchcombe M, White H. Multilayer feed forward networks are universal approximations. Neural Networks 1989; 2: 336–359.CrossRef
26.
go back to reference Zervos E, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010;210:564–574.PubMedCrossRef Zervos E, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010;210:564–574.PubMedCrossRef
27.
go back to reference Fried M, Ribaric G, Buchwald JN, Svacina S, Dolezalova K, Scopinaro N. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 Kg/m2 : An integrative review of early studies. Obes Surg 2010;20:776–790.PubMedCrossRef Fried M, Ribaric G, Buchwald JN, Svacina S, Dolezalova K, Scopinaro N. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 Kg/m2 : An integrative review of early studies. Obes Surg 2010;20:776–790.PubMedCrossRef
28.
go back to reference Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316–323PubMedCrossRef Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316–323PubMedCrossRef
29.
go back to reference Rosenthal R, Li X, Samuel S, et al. Effects of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Related Diseas 2009;5:429–434.CrossRef Rosenthal R, Li X, Samuel S, et al. Effects of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Related Diseas 2009;5:429–434.CrossRef
30.
go back to reference Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010;20:1245–1250.PubMedCrossRef Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010;20:1245–1250.PubMedCrossRef
31.
go back to reference Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450–5.PubMedCrossRef Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450–5.PubMedCrossRef
32.
go back to reference Lee WJ, Lee YC, Ser KH, et al. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008;18:1119–1125PubMedCrossRef Lee WJ, Lee YC, Ser KH, et al. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008;18:1119–1125PubMedCrossRef
33.
go back to reference Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients:Efficacy and change of insulin secretion. Surgery 2010;147:664–669.PubMedCrossRef Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients:Efficacy and change of insulin secretion. Surgery 2010;147:664–669.PubMedCrossRef
34.
go back to reference Dietel M. Surgery for diabetes at lower BMI: some caution (Editorial). Obesity Surg 2008;18:1211–1214.CrossRef Dietel M. Surgery for diabetes at lower BMI: some caution (Editorial). Obesity Surg 2008;18:1211–1214.CrossRef
36.
go back to reference Chang HY, Hsu CC, Pan WH, et al. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res & Clin Prac 2010;90:358–364.CrossRef Chang HY, Hsu CC, Pan WH, et al. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res & Clin Prac 2010;90:358–364.CrossRef
37.
go back to reference Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129–2140.PubMedCrossRef Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129–2140.PubMedCrossRef
38.
go back to reference Yokoyama H, Yamada H, Okudaira M, et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDDM patients. Diabetes Care 1998;21:1080–1085.PubMedCrossRef Yokoyama H, Yamada H, Okudaira M, et al. High incidence of diabetic nephropathy in early-onset Japanese NIDDDM patients. Diabetes Care 1998;21:1080–1085.PubMedCrossRef
39.
go back to reference DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes & Related Dis 2010;6:249–253.CrossRef DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes & Related Dis 2010;6:249–253.CrossRef
40.
go back to reference Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes & Reated Dis 2010;6:254–259.CrossRef Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes & Reated Dis 2010;6:254–259.CrossRef
Metadata
Title
Gastrointestinal Metabolic Surgery for the Treatment of Diabetic Patients: A Multi-Institutional International Study
Authors
Wei-Jei Lee
Kyung Yul Hur
Muffazal Lakadawala
Kazunori Kasama
Simon K. H. Wong
Yi-Chih Lee
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1740-2

Other articles of this Issue 1/2012

Journal of Gastrointestinal Surgery 1/2012 Go to the issue